Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
McBurnett, Keith
and
Pfiffner, Linda J.
2009.
Treatment of Aggressive ADHD in Children and Adolescents: Conceptualization and Treatment of Comorbid Behavior Disorders.
Postgraduate Medicine,
Vol. 121,
Issue. 6,
p.
158.
2010.
The Science of ADHD.
p.
240.
Sallee, Floyd R.
2010.
The Role of Alpha2-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder.
Postgraduate Medicine,
Vol. 122,
Issue. 5,
p.
78.
McCracken, James T.
Aman, Michael G.
McDougle, Christopher J.
Tierney, Elaine
Shiraga, Sharon
Whelan, Fiona
Arnold, L. Eugene
Posey, David
Ritz, Louise
Vitiello, Benedetto
and
Scahill, Lawrence
2010.
Possible Influence of Variant of the P-Glycoprotein Gene (MDR1/ABCB1) on Clinical Response to Guanfacine in Children with Pervasive Developmental Disorders and Hyperactivity.
Journal of Child and Adolescent Psychopharmacology,
Vol. 20,
Issue. 1,
p.
1.
Kooij, Sandra JJ
Bejerot, Susanne
Blackwell, Andrew
Caci, Herve
Casas-Brugué, Miquel
Carpentier, Pieter J
Edvinsson, Dan
Fayyad, John
Foeken, Karin
Fitzgerald, Michael
Gaillac, Veronique
Ginsberg, Ylva
Henry, Chantal
Krause, Johanna
Lensing, Michael B
Manor, Iris
Niederhofer, Helmut
Nunes-Filipe, Carlos
Ohlmeier, Martin D
Oswald, Pierre
Pallanti, Stefano
Pehlivanidis, Artemios
Ramos-Quiroga, Josep A
Rastam, Maria
Ryffel-Rawak, Doris
Stes, Steven
and
Asherson, Philip
2010.
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.
BMC Psychiatry,
Vol. 10,
Issue. 1,
Muir, Victoria J.
and
Perry, Caroline M.
2010.
Guanfacine Extended-Release.
Drugs,
Vol. 70,
Issue. 13,
p.
1693.
Sallee, Floyd R
and
Eaton, Katherine
2010.
Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).
Expert Opinion on Pharmacotherapy,
Vol. 11,
Issue. 15,
p.
2549.
May, Diane E.
and
Kratochvil, Christopher J.
2010.
Attention-Deficit Hyperactivity Disorder.
Drugs,
Vol. 70,
Issue. 1,
p.
15.
Cinnamon Bidwell, L.
Dew, Rachel E.
and
Kollins, Scott H.
2010.
Alpha-2 Adrenergic Receptors and Attention-Deficit/Hyperactivity Disorder.
Current Psychiatry Reports,
Vol. 12,
Issue. 5,
p.
366.
2011.
ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
Pediatrics,
Vol. 128,
Issue. 5,
p.
1007.
Hong, Irene Seunghyun
Ipema, Heather J
Gabay, Michael P
and
Lodolce, Amy E
2011.
Medication Repurposing: New Uses for Old Drugs.
Journal of Pharmacy Technology,
Vol. 27,
Issue. 3,
p.
132.
Huang, Yu-Shu
and
Tsai, Ming-Horng
2011.
Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder.
CNS Drugs,
Vol. 25,
Issue. 7,
p.
539.
Antshel, Kevin M
Hargrave, Teresa M
Simonescu, Mihai
Kaul, Prashant
Hendricks, Kaitlin
and
Faraone, Stephen V
2011.
Advances in understanding and treating ADHD.
BMC Medicine,
Vol. 9,
Issue. 1,
Greydanus, Donald E.
2011.
Neurodevelopmental Disabilities.
p.
111.
Heal, David J.
Smith, Sharon L.
and
Findling, Robert L.
2011.
Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder and Its Treatment.
Vol. 9,
Issue. ,
p.
361.
Paterson, Neil E.
Ricciardi, Jennifer
Wetzler, Caitlin
and
Hanania, Taleen
2011.
Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
Neuroscience Research,
Vol. 69,
Issue. 1,
p.
41.
Geissler, Julia
and
Lesch, Klaus-Peter
2011.
A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms.
Expert Review of Neurotherapeutics,
Vol. 11,
Issue. 10,
p.
1467.
Elia, Josephine
Wilson, Zoe
La Porta, Lilly Sehgal
Algon, Sibel A
Prowler, Matthew L
Cartwright, Shanique T
McKenna, Patricia A
Laracy, Seth
Takeda, Toshinobu
and
Borgmann-Winter, Karin
2011.
Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.
Expert Review of Clinical Pharmacology,
Vol. 4,
Issue. 3,
p.
311.
Kaplan, Gabriel
and
Newcorn, Jeffrey H.
2011.
Pharmacotherapy for Child and Adolescent Attention-deficit Hyperactivity Disorder.
Pediatric Clinics of North America,
Vol. 58,
Issue. 1,
p.
99.
Clement, Hans‐Willi
and
Schulz, Eberhard
2011.
α2‐Agonisten und adrenerge Pharmaka bei ADHS.
Pharmazie in unserer Zeit,
Vol. 40,
Issue. 6,
p.
503.